TechFundies's profile picture. Tech investor for ~25 years. Ran large hedge fund for 10 of those. Here to help. Not investment advice.

TechStockFundamentals

@TechFundies

Tech investor for ~25 years. Ran large hedge fund for 10 of those. Here to help. Not investment advice.

고정된 트윗

I think there are basically 2 prevailing strategies in the market. 1) Earnings revisions Only two questions matter near-term: Is the story getting better or worse, and are numbers going up or down? That's it. For momentum names, in either direction, that's all that matters…


$JPM released AI search product today. Pretty cool.

TechFundies's tweet image. $JPM released AI search product today.  Pretty cool.

Interesting insights from $PLTR former. Certainly seems like they are onto something as far as go-to-market fit. Highlights -Joined PLTR to help get commercial strategy working -Companies were reluctant to work w/ PLTR – worked w/ ICE, etc. -Figured out should go pitch…


I think everyone is a bit off base with these net new ARR acceleration hopes ($CRM, $HUBS, etc.) Here is a simple example where a subscription business landing the same new ARR each quarter is growing 18% yy. Then, new ARR bumps up to 25% yy growth. Sub revenue takes 3…

TechFundies's tweet image. I think everyone is a bit off base with these net new ARR acceleration hopes ($CRM, $HUBS, etc.)

Here is a simple example where a subscription business landing the same new ARR each quarter is growing 18% yy.  

Then, new ARR bumps up to 25% yy growth.

Sub revenue takes 3…

$HUBS reported a fine quarter but below expectations of an acceleration. Story is moving sideways. Decent SaaS product cycle story but AI impact unclear. Also unclear if this is a great business. Numbers likely move higher but also seems unlikely company is able to…

TechFundies's tweet image. $HUBS reported a fine quarter but below expectations of an acceleration.

Story is moving sideways.  Decent SaaS product cycle story but AI impact unclear.  Also unclear if this is a great business.

Numbers likely move higher but also seems unlikely company is able to…

Three third-party WDAY partner checks were constructive. Leading platform for HCM / FINS, Extend allows customers to customize solution which opens up deployment use cases, AI still early but a call option. Up-market getting more penetrated but mid-market / government has…

TechFundies's tweet image. Three third-party WDAY partner checks were constructive.

Leading platform for HCM / FINS, Extend allows customers to customize solution which opens up deployment use cases, AI still early but a call option.

Up-market getting more penetrated but mid-market / government has…

In defense of Sam: 1) He is focused on the big picture and transformational tech. This dude started with a lab that was working on pretty experimental stuff and has shot the lights out thus far. 2) He has the world's biggest plate - managing an AI talent pool that is…


Interesting AI data point from my exceptional NYC doctor (highly recommend for family medicine), who also writes a great blog (link below) For the first time, New England Journal Of Medicine published its weekly case review with an AI perspective as well. They pitted a master…

TechFundies's tweet image. Interesting AI data point from my exceptional NYC doctor (highly recommend for family medicine), who also writes a great blog (link below)

For the first time, New England Journal Of Medicine published its weekly case review with an AI perspective as well.

They pitted a master…
TechFundies's tweet image. Interesting AI data point from my exceptional NYC doctor (highly recommend for family medicine), who also writes a great blog (link below)

For the first time, New England Journal Of Medicine published its weekly case review with an AI perspective as well.

They pitted a master…
TechFundies's tweet image. Interesting AI data point from my exceptional NYC doctor (highly recommend for family medicine), who also writes a great blog (link below)

For the first time, New England Journal Of Medicine published its weekly case review with an AI perspective as well.

They pitted a master…
TechFundies's tweet image. Interesting AI data point from my exceptional NYC doctor (highly recommend for family medicine), who also writes a great blog (link below)

For the first time, New England Journal Of Medicine published its weekly case review with an AI perspective as well.

They pitted a master…

My $AMZN estimates moved up. Remains an attractive revision / risk-reward setup. Have to say, $GOOGL Gemini Pro in Chrome is turning into a must-have backup to my own analysis.

TechFundies's tweet image. My $AMZN estimates moved up. 

Remains an attractive revision / risk-reward setup.

Have to say, $GOOGL Gemini Pro in Chrome is turning into a must-have backup to my own analysis.
TechFundies's tweet image. My $AMZN estimates moved up. 

Remains an attractive revision / risk-reward setup.

Have to say, $GOOGL Gemini Pro in Chrome is turning into a must-have backup to my own analysis.

$NOW reported a solid qtr. Story is solid as they remain the operational workflow workhorse for enterprise, and are layering in AI functionality. Numbers have some room to move higher. Risk / reward is ok. High margin, high-retention subscription business that ought to decel…

TechFundies's tweet image. $NOW reported a solid qtr.

Story is solid as they remain the operational workflow workhorse for enterprise, and are layering in AI functionality.

Numbers have some room to move higher.

Risk / reward is ok.

High margin, high-retention subscription business that ought to decel…

Loading...

Something went wrong.


Something went wrong.